Neutropenia: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(41 intermediate revisions by 6 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{DiseaseDisorder infobox |
Name = Neutropenia |
ICD10 = {{ICD10|D|70||d|70}} |
ICD9 = {{ICD9|288.0}} |
}}
{{ Neutropenia }}
{{ Neutropenia }}
'''Editor-in-Chief:''' Aric Hall, M.D. Beth Israel Deaconess Medical Center, Boston, MA[mailto:achall@bidmc.harvard.edu]; [[C. Michael Gibson]], M.S., M.D.
{{CMG}}; Aric Hall, M.D. Beth Israel Deaconess Medical Center, Boston, MA[mailto:achall@bidmc.harvard.edu] {{AE}}{{DG}}, {{Faizan}}


==Overview==
{{SK}}  Agranulocytosis, agranulosis, benign familial neutropenia, chronic benign neutropenia, cyclic neutropenia, CN, cyclic hematopoiesis, granulocytopenia, granulopenia, human cyclic neutropenia, neutropaenia, neutrophilic leukopenia, neutrophilic leukocytopenia, neutrophilic leucopenia, neutrophilic leucocytopenia
'''Neutropenia''' (or '''neutropaenia''', adjective '''neutrop(a)enic''') is a [[Hematology|hematological]] disorder characterized by an abnormally low number of [[neutrophil granulocyte]]s (a type of [[white blood cell]]). Neutrophils usually make up 50-70% of circulating white blood cells and serve as the primary defense against [[infection]]s by destroying [[bacterium|bacteria]] in the [[blood]]. Hence, patients with neutropenia are more susceptible to bacterial infections and without prompt medical attention, the condition may become life-threatening. Neutropenia can be [[Acute (medical)|acute]] or [[chronic (medicine)|chronic]] depending on the duration of the illness. A patient has chronic neutropenia if the condition lasts for greater than 3 months. It is sometimes used interchangeably with the term [[leukopenia]]. However, neutropenia is more properly considered a subset of leukopenia as a whole.


==Classification==
Neutropenia is defined absolute neutrophil count < 1.5 x 10<sup>9</sup>/L.
There are 3 general guidelines used to classify the severity of neutropenia based on the absolute neutrophil count (ANC) measured in cells per [[microliter]] of blood:
* Mild neutropenia (1000 < ANC < 1500) &mdash; minimal risk of infection
* Moderate neutropenia (500 < ANC < 1000) &mdash; moderate risk of infection
* Severe neutropenia (ANC < 500) &mdash; severe risk of infection.
NOTE: These are ranges for Caucasians. Neutropenia in black individuals is defined as ANC < 1200. This is a not well known fact that results in overdiagnosis of neutropenia in black population.<ref name="pmid17404350">{{cite journal |author=Hsieh MM, Everhart JE, Byrd-Holt DD, Tisdale JF, Rodgers GP |title=Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences |journal=Ann. Intern. Med. |volume=146 |issue=7 |pages=486-92 |year=2007 |pmid=17404350 |doi= |url=http://www.annals.org/cgi/content/abstract/146/7/486}}</ref>


==Types==
Agranulocytosis is defined as severe neutropenia < 0.5 x 10<sup>9</sup>/L.
Severe chronic neutropenia may be present at birth (congenital neutropenia) or may occur at any stage in life (acquired neutropenia).
There are several types of severe chronic neutropenia:


'''Severe [[congenital]] neutropenia''' &mdash; a rare inherited form of the disease usually detected soon after birth. It affects children mainly and may result in premature loss of teeth and peremptory gum infections. The most severe form of chronic congenital neutropenia is known as [[Kostmann syndrome|Kostmann’s syndrome]]. It is genetically heterogeneous. Most commonly, it arises as a result of new, [[autosomal]] [[dominant gene|dominant]] mutations in the gene, ELA2, encoding the neutrophil granule [[protease]], [[neutrophil elastase]], NE. The gene responsible for many cases of autosomal recessively inherited severe congenital neutropenia is HAX1. The mechanism for congenital neutropenia is not well-understood. There is evidence that mutations in neutrophil elastase, or in other genes associated with syndromic forms of neutropenia, disrupt its intracellular trafficking. [[Apoptosis]] may be a final effector for neutropenia, but the original studies from Dale and Aprikian supporting this pathway were retracted.
Although agranulocytosis and granulocytopenia should include reduced numbers of all granulocytes (either neutrophils, eosinophils, or basophils), the majority of cases of granulocytopenia are actually neutropenia since neutrophils constitute the majority of leukocytes; the term granulocytopenia almost always refers to deficient neutrophils. To read about eosinophilic leukopenia and basophilic leukopenia, click [[leukopenia|here]].


'''Cyclic neutropenia''' &mdash; tends to occur every three weeks and lasting three to six days at a time due to changing rates of cell production by the bone marrow. It is often present among several members of the same family. Cyclic neutropenia is also the result of autosomal dominantly inherited mutations in ELA2, the gene encoding neutrophil elastase.
==[[Neutropenia overview|Overview]]==


'''Idiopathic neutropenia''' &mdash; a rare form of neutropenia which develops in children and adults usually in response to an illness. It is diagnosed when the disorder cannot be attributed to any other diseases and often causes life-threatening infections.
==[[Neutropenia historical perspective|Historical Perspective]]==


'''Myelokathexis''' &mdash; a rare form of inherited autosomal dominant disease associated with severe neutropenia. Some but not all patients have Warts, [[Hypogammaglobulinemia]], and recurrent Infections. Therefore myelokathexis is also known as the W.H.I.M. syndrome. In spite of severe neutropenia (low number of neutrophils) in peripheral blood of myelokathexis patients, their bone marrow is hypercellular and it is packed with mature neutrophils indicating an impaired mobilization of [[hematopoietic]] cells in this disorder. Truncating mutations in the human [[cytokine receptor]] CXCR4 gene were identified in most of the families afflicted by myelokathexis. The molecular mechanism is not yet defined. Recent reports demonstrate that CXCR4 mutations appear to result in an increased sensitivity of bone marrow hematopoietic cells to its ligand, a stromal-derived growth factor SDF-1 that provides proliferative and survival signals.
==[[Neutropenia classification|Classification]]==


'''Autoimmune neutropenia''' &mdash; most common in infants and young children where the body identifies the neutrophils as enemies and makes [[antibodies|antibody]] to destroy them. This form usually lessens in severity within two years of [[diagnosis]].
==[[Neutropenia pathophysiology|Pathophysiology]]==


'''Drug-induced neutropenia''' &mdash; Many drugs can cause agranulocytosis (complete absence of white cells) and neutropenia. Many [[chemotherapy|anti-neoplastic drugs]] cause agranulocytosis and neutropenia by bone marrow suppression. Neutropenia and agranulocytosis can also result from [[antibody]] or [[complement system|complement]]-mediated damage to the stem cells. Some drugs may cause increased peripheral destruction of white cells. About 75% of all cases of agranulocytosis in the United States are related to medication. [[Clozapine]], [[procainamide]], anti-thyroid drugs (e.g. [[methimazole]], and [[sulfasalazine]] are at the top of the list of drugs causing this problem, but many others (such as [[antiepileptic]]s) have been implicated.
==[[Neutropenia causes|Causes]]==


==Differential diagnosis of causes of neutropenia==
==[[Neutropenia differential diagnosis|Differentiating Neutropenia from other Diseases]]==
Causes can be divided into the following groups:
* Decreased production in the [[bone marrow]]:
** [[Hereditary disorder]]s (e.g. congenital neutropenia, [[Cyclic neutropenia]])
** [[Cancer]]
** [[Drugs]]
** [[Radiation]]
** [[cobalamin|Vitamin B<sub>12</sub>]] or [[folate]] deficiency.
* Increased destruction:
** [[Aplastic anemia]]
** [[autoimmune disorder|Autoimmune]] neutropenia.
** [[Chemotherapy]]
* Marginalisation and sequestration:
** [[dialysis|Hemodialysis]]


There is usually a mild neutropenia in [[viral infection]]s.
==[[Neutropenia epidemiology and demographics|Epidemiology and Demographics]]==


==Signs and symptoms==
==[[Neutropenia risk factors|Risk Factors]]==
Neutropenia can go undetected, but is generally discovered when a patient has developed severe [[infection]]s or [[sepsis]]. Some common infections can take an unexpected course in neutropenic patients; formation of [[pus]], for example, can be notably absent, as this requires circulating neutrophil granulocytes.


Some common symptoms of neutropenia include:
==[[Neutropenia screening|Screening]]==
*[[Fever]]
 
*Frequent [[infections]] due to lessened ability to fight [[bacterial]] infections
==[[Neutropenia natural history, complications and prognosis|Natural History, Complications, and Prognosis]]==
*Mouth [[ulcers]]
*[[Diarrhea]]
*[[Burning sensation when urinating]]
*Unusual redness, pain, or [[swelling]] around a wound
*[[Sore throat]]
*[[Shortness of breath]]
*Shaking [[chills]]


==Diagnosis==
==Diagnosis==
Low neutrophil counts are detected on a [[full blood count]].  A [[peripheral blood smear]] is often useful to evaluate for abnormal morphology of the visible cells, which may help suggest the diagnosis.  Evaluation for metabolic abnormalities, genetic causes neutropenia, and/or other underlying metabolic or toxic causes will often follow.  When the etiology is uncertain, or serious causes such as malignancy and marrow replacement are suspected, [[bone marrow biopsy]] is often necessary.
[[Neutropenia history and symptoms|History and Symptoms]] | [[Neutropenia physical examination|Physical Examination]] | [[Neutropenia laboratory findings|Laboratory Findings]] | [[Neutropenia chest x ray|X Ray]] | [[Neutropenia CT|CT]] | [[Neutropenia MRI|MRI]] | [[Neutropenia ultrasound|Ultrasound]] | [[Neutropenia other imaging findings|Other Imaging Findings]] | [[Neutropenia other diagnostic studies|Other Diagnostic Studies]]
 
==Therapy==
There is no ideal therapy for neutropenia, but recombinant [[Granulocyte-colony stimulating factor|G-CSF]] (granulocyte-colony stimulating factor) can be effective in chemotherapy patients, in patients with congenital forms of neutropenia including severe congenital neutropenia, autosomal recessive Kostmann's syndrome, cyclic neutropenia, myelokathexis, and some other causes...
 
==See also==
* [[Aplastic anemia]]
* [[Pancytopenia]]
* [[Thrombocytopenia]]


==References==
==Treatment==
{{reflist|2}}
[[Neutropenia medical therapy|Medical Therapy]] | [[Neutropenia surgery|Surgery]] | [[Neutropenia primary prevention|Primary Prevention]] | [[Neutropenia secondary prevention|Secondary Prevention]] | [[Neutropenia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Neutropenia future or investigational therapies|Future or Investigational Therapies]]


{{Hematology}}
{{Hematology}}


[[de:Neutropenie]]
[[es:Agranulocitosis]]
[[fr:Neutropénie]]
[[it:Neutropenia]]
[[nl:Neutropenie]]
[[pl:Neutropenia]]
[[pt:Neutropenia]]
[[sq:Neutropenia]]
[[tr:Granülositopeni]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}



Latest revision as of 16:46, 24 October 2016

Neutropenia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neutropenia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neutropenia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neutropenia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neutropenia

on Neutropenia

Neutropenia in the news

Blogs on Neutropenia

Directions to Hospitals Treating Neutropenia

Risk calculators and risk factors for Neutropenia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Aric Hall, M.D. Beth Israel Deaconess Medical Center, Boston, MA[2] Associate Editor(s)-in-Chief: Daniel A. Gerber, M.D. [3], Faizan Sheraz, M.D. [4]

Synonyms and keywords: Agranulocytosis, agranulosis, benign familial neutropenia, chronic benign neutropenia, cyclic neutropenia, CN, cyclic hematopoiesis, granulocytopenia, granulopenia, human cyclic neutropenia, neutropaenia, neutrophilic leukopenia, neutrophilic leukocytopenia, neutrophilic leucopenia, neutrophilic leucocytopenia

Neutropenia is defined absolute neutrophil count < 1.5 x 109/L.

Agranulocytosis is defined as severe neutropenia < 0.5 x 109/L.

Although agranulocytosis and granulocytopenia should include reduced numbers of all granulocytes (either neutrophils, eosinophils, or basophils), the majority of cases of granulocytopenia are actually neutropenia since neutrophils constitute the majority of leukocytes; the term granulocytopenia almost always refers to deficient neutrophils. To read about eosinophilic leukopenia and basophilic leukopenia, click here.

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neutropenia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Template:Hematology